Literature DB >> 6449702

A human soluble suppressor factor affecting lymphocyte responses in vitro.

L Shou, S A Schwartz, R A Good, R Peng, C L Chen.   

Abstract

A soluble suppressor factor (SSF) has been demonstrated in the supernatant of normal human peripheral blood lymphocyte cultures that exhibits suppressive activity toward the proliferative response of normal lymphocytes to concanavalin A or alloantigens in mixed lymphocyte culture (MLC) or toward pokeweed mitogen-stimulated immunoglobulin synthesis and secretion in vitro. Suppression of the proliferative response in MLC reached maximal levels when added SSF-containing supernatant approximated 20% by volume of the culture medium. Suppression in the MLC was found to act at the proliferative stage. SSF acts independently of cytotoxicity and is stable at 56 degrees C for 30 min but is inactivated at higher temperatures. Addition of SSF to the MLC as late as day 4 after initiation of the culture results in suppression of transformation. This factor(s) may regulate the magnitude of several immune responses in humans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449702      PMCID: PMC350220          DOI: 10.1073/pnas.77.10.6096

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Disparity in the production of lymphoblastogenesis inhibition factor by cultured human B and T lymphoid cell lines.

Authors:  T Han; J L Pauly; J Minowada
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Functional heterogeneity among the T-derived lymphocytes of the mouse. IV. Nature of spontaneously induced suppressor cells.

Authors:  F D Burns; P C Marrack; J W Kappler; C A Janeway
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

3.  Regulatory mechanisms in cell-mediated immune responses. II. Comparison of culture-induced and alloantigen-induced suppressor cells in MLR and CML.

Authors:  L M Nadler; R J Hodes
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

4.  Mitogen-stimulated lymphocyte inhibition by supernatants of crowded lymphocytoblasts.

Authors:  S S Green; R Wistar; K W Sell
Journal:  Transplantation       Date:  1974-12       Impact factor: 4.939

5.  Mechanism of production of inhibitor of lymphocyte blastogenic response to mitogens by cultured lymphoblastoid cell line cells.

Authors:  E M Hersh; K B McCredie; E J Freireich
Journal:  Transplantation       Date:  1974-02       Impact factor: 4.939

6.  Antigenic competition between heterologous erythrocytes. I. Thymic dependency.

Authors:  R K Gershon; K Kondo
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

7.  Characterization of lymphocyte inhibition by supernatants of crowded lymphocytoblasts.

Authors:  S S Green; R Wistar
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

9.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Active suppression of immunoglobulin allotype synthesis. 3. Identification of T cells as responsible for suppression by cells from spleen, thymus, lymph node, and bone marrow.

Authors:  L A Herzenberg; E L Chan; M M Ravitch; R J Riblet; L A Herzenberg
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  6 in total

1.  Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.

Authors:  T Iwasaka; J F Sheridan; L Aurelian
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

Review 2.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

3.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

4.  Human B cell growth factors overcome T cell-mediated inhibition of specific antibody production: a possible mechanism for the exacerbation of autoimmune disease.

Authors:  M K Brenner; M E North
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

5.  Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.

Authors:  J B Putnam; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.

Authors:  D L Rosenstreich; J H Tu; P R Kinkade; I Maurer-Fogy; J Kahn; R W Barton; P R Farina
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.